Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Conditions: Neoadjuvant Immunotherapy; Cervical Cancer; Fertility-sparing Surgery Interventions: Drug: AK104; Drug: Carboplatin; Drug: Nab paclitaxel Sponsors: Xiaohua Wu Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cervical Cancer | Immunotherapy | Neoadjuvant Therapy | Reproduction Medicine | Research | Study